Retraction
Mutual regulation of Bcl-2 proteins independent of the BH3 domain as shown by the BH3-lacking protein Bcl-x(AK)
Paper Information
Record ID:
64755
Author(s):
Publication Date:
April 10, 2012
Retraction Date:
November 22, 2024
(<1 year years ago)
Subjects:
Institutions:
Country:
🇩🇪 GermanyArticle Type:
Publisher:
PLoS
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1371/journal.pone.0314638Citations (11)
11
Total Citations0
Post-Retraction9
Pre-Retraction1
Same DayHeavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Retraction: Mutual Regulation of Bcl-2 Proteins Independent of the BH3 Domain as Shown by the BH3-Lacking Protein Bcl-xAK
Unknown Authors
PLoS ONE
Open Access
Published: Nov 2024
Same day as retraction
Cancer Resistance Is Mediated by the Upregulation of Several Anti-Apoptotic Gene Products <i>via</i> the Inducible Nitric Oxide Synthase/Nitric Oxide Pathway: Therapeutic Implications
Indy Bui, Stavroula Baritaki, Massimo Libra et al. (5 authors)
Antioxidants and Redox Signaling
Published: Feb 2023
4 citations
4 citations
639 days before retraction
Understanding and drugging the Bcl-2 transmembrane interactome for tumor treatment
Estefanía Lucendo Gutiérrez
Unknown Journal
Open Access
Published: Oct 2020
1500 days before retraction
Modulation of the Apoptosis Gene Bcl-x Function Through Alternative Splicing
Megan Stevens, Sebastian Oltean
Frontiers in Genetics
Open Access
Published: Sep 2019
118 citations
118 citations
1904 days before retraction
Countering TRAIL Resistance in Melanoma
Jürgen Eberle
Cancers
Open Access
Published: May 2019
44 citations
44 citations
2022 days before retraction
Paper citing Mutual regulation of Bcl-2 proteins independent of...
Unknown Authors
Unknown Journal
Published: May 2019
2022 days before retraction
Regulation of Apoptosis in Melanoma Cells: Critical Targets for Therapeutic Strategies
Jürgen Eberle, Lothar F. Fecker
Springer eBooks
Published: Jan 2017
2 citations
2 citations
2882 days before retraction
<scp>BH</scp>3‐only proteins – possible proapoptotic triggers for melanoma therapy
Michael Plötz, Jürgen Eberle
Experimental Dermatology
Published: Mar 2014
14 citations
14 citations
3892 days before retraction
The BH3-only protein BimL overrides Bcl-2-mediated apoptosis resistance in melanoma cells
Michael Plötz, Bernhard Gillissen, Sandra-Annika Quast et al. (6 authors)
Cancer Letters
Published: Feb 2013
18 citations
18 citations
4304 days before retraction
Disruption of the VDAC2–Bak interaction by Bcl-xS mediates efficient induction of apoptosis in melanoma cells
Michael Plötz, Bernhard Gillissen, Amir M. Hossini et al. (5 authors)
Cell Death and Differentiation
Open Access
Published: Jun 2012
59 citations
59 citations
4543 days before retraction
Quick Stats
Total Citations:
11
Years Since Retraction:
<1 year
Open Access:
Yes
Last Checked:
Jul 24, 2025